Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3032567	s-hbvnh	— (—)	1158	1953	100.00%	Distribution not available
3032567	-hbvnh	— (—)	82	111	100.00%	Distribution not available
3032567	p-hbvnh	— (—)	75	79	100.00%	Distribution not available
3032567	s-hbvnh	IU/ml (iu/ml)	35	75	36.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other viral hepatitis, including avohilmo

202

33.31

313.36

4.4

1.2

20625223.69

—

iu/ml

—

Viral hepatitis, including avohilmo

219

30.74

307.65

4.2

1.2

20625223.69

—

iu/ml

—

Chronic viral hepatitis

175

37.12

279.75

4.9

1.2

23571643.57

—

iu/ml

—

Any gastric operation

251

403

3.13

49.50

1.9

1.3

175.33

106.29

iu/ml

—

GASTRO-related operations

251

403

3.13

49.50

1.9

1.3

175.33

106.29

iu/ml

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

298

929

2.17

31.57

1.7

66000135.00

142.54

iu/ml

—

Substance use, excluding alcohol

278

3.48

27.81

1.3

1.8

—

161.29

—

Bacterial Sepsis

152

472

2.67

26.78

1.4

1.7

—

188.00

iu/ml

—

General symptoms and signs

303

752

2.02

25.06

1.8

1.6

129.14

27500205.67

iu/ml

—

Implicit bacterial Sepsis

133

424

2.70

24.17

1.4

1.6

—

218.83

iu/ml

—

Implicit bacterial Sepsis, including avohilmo

138

459

2.51

21.59

1.4

1.7

—

206.14

iu/ml

—

ILD medications

310

901

1.86

20.64

1.6

1.7

171.50

23571605.21

iu/ml

—

First line medication for Crohn's disease

299

885

1.82

18.76

1.6

1.7

171.50

23571605.21

iu/ml

—

ILD medications: prednisolone, methylprednisolone, prednisone

290

882

1.83

18.66

1.5

1.7

203.20

23571605.21

iu/ml

—

Chronic periodontitis, including avohilmo

261

933

1.79

16.16

1.9

1.6

211.00

122.83

iu/ml

—

Periodontitis

261

934

1.78

16.04

1.9

1.6

257.50

89.45

iu/ml

—

Other acute viral hepatitis

18.88

13.47

1.4

1.1

—

Implicit viral Sepsis, including avohilmo

364

2.42

13.47

1.3

1.6

—

208.60

iu/ml

—

Human immunodeficiency virus [HIV] disease

12.57

12.67

2.2

1.8

—

iu/ml

—

Human immunodeficiency virus [HIV] disease, including avohilmo

11.90

12.38

2.2

1.7

—

iu/ml

—

Persons with potential health hazards related to communicable diseases

113

536

2.09

12.28

2.0

1.7

185.83

236.67

iu/ml

—

Kela reimbursement Agammaglobulinemia (D80-84)

18.96

12.19

1.2

2.2

—

iu/ml

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

12.09

11.39

2.3

1.8

—

iu/ml

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

116

352

2.08

11.33

1.6

2.0

—

233.25

iu/ml

—

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

11.42

11.10

2.2

1.8

—

iu/ml

—

Inflammatory bowel disease treatment related agents

281

986

1.58

10.95

1.6

1.7

185.57

23571605.21

iu/ml

—

Gingivitis and periodontal diseases

231

717

1.67

10.86

1.7

1.6

178.17

328.60

iu/ml

—

Neoplasms

197

598

1.73

10.67

1.8

1.6

84.00

318.86

iu/ml

—

Oral corticosteroids

256

943

1.59

10.42

1.6

1.7

251.00

25384804.54

iu/ml

—

Assault

199

2.68

10.08

1.8

—

161.43

iu/ml

—

Malaise and fatigue

123

512

1.89

9.79

1.4

1.6

—

137.67

iu/ml

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

332

2.24

9.73

1.9

1.7

—

265.90

iu/ml

—

Other soft tissue disorders, not elsewhere classified

227

807

1.60

9.44

1.7

209.00

166.73

iu/ml

—

Chronic apical periodontitis

265

965

1.54

9.34

1.6

1.7

125.60

20625196.50

iu/ml

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

8.76

8.83

1.2

1.7

—

Persons encountering health services in other circumstances, wide

271

918

1.52

8.80

1.6

1.7

33.00

23571681.50

iu/ml

—

Second line medication for Crohn's disease

146

851

1.72

8.80

1.5

1.7

—

161.67

iu/ml

—

Unspecified human immunodeficiency virus [HIV] disease

14.48

8.76

1.8

1.0

—

iu/ml

—

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

13.14

8.43

1.8

1.0

—

iu/ml

—

Certain disorders involving the immune mechanism

244

2.34

8.31

1.3

1.7

—

207.60

iu/ml

—

Other specific joint derangements/joint disorders

157

584

1.68

8.05

2.1

1.9

273.80

165.91

iu/ml

—

Nonhereditary hypogammaglobulinemia

13.37

7.93

1.2

2.2

—

iu/ml

—

Soft tissue disorders

242

817

1.52

7.91

1.5

1.7

249.20

166.73

iu/ml

—

L04AX Other immunosuppressants

139

831

1.67

7.71

1.5

1.7

—

161.67

iu/ml

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

3.76

6.95

1.4

1.3

—

iu/ml

—

Other viral diseases, including avohilmo

553

1.78

6.83

1.4

1.8

—

244.31

iu/ml

—

Reactive arthropathies, FINNGEN

3.58

6.58

2.7

2.1

—

iu/ml

—

Autoimmune hepatitis

10.30

6.58

1.3

2.0

—

Primary biliary cholangitis, wide definition

6.91

6.53

1.2

1.8

—

Dissocial personality disorder

7.51

6.44

1.1

1.8

—

Pneumocystosis

7.77

6.14

1.5

1.9

—

Pneumocystosis, including avohilmo

7.77

6.14

1.5

1.9

—

Hypoplasia of dental enamel

12.76

6.10

1.3

—

Pain (limb, back, neck, head abdominally)

166

537

1.55

6.06

1.7

207.60

55000218.17

iu/ml

—

Special screening examination for infectious and parasitic diseases

261

1.93

5.92

1.8

—

212.86

—

Acute alcohol intoxication

351

1.91

5.92

1.3

1.8

—

185.83

iu/ml

—

Non-invasive ventilation

267

1.98

5.78

1.2

1.9

—

176.00

iu/ml

—

Leukaemia of unspecified cell type

13.14

5.61

1.1

2.6

—

Colitis, primary sclerosing, strict definition

8.66

5.59

1.1

2.3

—

Used for control exclusion in common control thyroid runs

242

866

1.41

5.58

1.8

1.7

223.60

208.36

iu/ml

—

Diseases of the digestive system

100

597

1.66

5.57

1.3

1.7

—

152.38

iu/ml

—

Cutaneous abscess, furuncle and carbuncle

372

1.83

5.31

1.4

1.7

—

185.83

iu/ml

—

Other viral diseases

430

1.76

5.24

1.5

1.8

—

136.91

iu/ml

—

Alcohol abuse, main dg, excluding more controls

208

2.12

5.21

1.5

1.7

—

185.83

iu/ml

—

Need for other prophylactic measures

3.14

5.19

1.9

1.5

—

Syncope and collapse

471

1.67

5.17

1.3

1.6

—

152.00

iu/ml

—

Other necrotizing vasculopathies (FG)

4.47

5.05

1.3

3.0

—

Acute alcohol intoxication, ICD10

296

1.90

4.89

1.4

1.7

—

178.17

iu/ml

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

236

917

1.37

4.69

1.8

1.7

33.00

23571681.50

iu/ml

—

6-mercaptopurine

4.32

4.63

1.1

1.9

—

iu/ml

—

Common variable immunodeficiency

14.37

4.60

1.4

3.2

—

iu/ml

—

Transport accidents

107

570

1.56

4.59

1.9

1.8

—

228.19

iu/ml

—

Dermatitis and eczema

242

1065

1.35

4.45

1.8

1.7

121.17

22000203.00

iu/ml

—

Alcohol abuse, main dg

222

1.99

4.43

1.5

1.7

—

207.60

iu/ml

—

Fracture of skull and facial bones

329

1.80

4.40

1.8

1.7

—

178.17

—

Other and unspecified nonorganic psychotic disorders

276

1.85

4.20

1.4

1.7

—

159.00

iu/ml

—

Bipolar affective disorders

257

1.87

4.10

1.7

1.9

—

149.20

—

Hepatomegaly and splenomegaly, not elsewhere classified

10.16

4.02

1.7

1.6

—

Folate deficiency anaemia

10.15

4.02

1.0

2.9

—

Schizophrenia or delusion, excluding more controls

416

1.66

4.01

1.3

1.7

—

149.10

iu/ml

—

Care involving use of rehabilitation procedures

132

823

1.44

3.97

1.4

1.7

—

22000146.27

iu/ml

—

Anxiety (asthma-related co-morbidities)

132

693

1.45

3.95

1.7

—

206.44

iu/ml

—

GI-bleeding

395

1.67

3.88

1.5

—

207.60

iu/ml

—

Other diseases of the digestive system

396

1.67

3.85

1.4

1.6

—

207.60

iu/ml

—

Need for immunization against other single viral diseases

5.32

3.83

1.4

1.8

—

Specific personality disorders

332

1.72

3.72

1.5

1.9

—

159.00

—

Dorsopathies

218

832

1.33

3.64

1.9

1.6

35.33

25384864.31

iu/ml

—

Other anxiety disorders

102

584

1.49

3.59

1.8

1.6

—

232.86

iu/ml

—

Early syphilis

6.24

3.51

4.8

2.2

—

Pain, not elsewhere classified

332

1.69

3.46

2.0

1.7

—

169.29

—

Viral infections characterized by skin and mucous membrane lesions

614

1.50

3.45

1.4

1.7

—

137.45

iu/ml

—

Asymptomatic human immunodeficiency virus [HIV] infection status

8.77

3.28

1.8

1.0

—

iu/ml

—

Disorders of adult personality and behaviour

417

1.59

3.21

1.7

1.8

—

149.20

—

Early syphilis, including avohilmo

5.40

3.20

4.8

2.1

—

All anxiety disorders

135

761

1.38

3.14

1.7

—

197.47

iu/ml

—

Hallux rigidus

105

2.19

3.08

1.3

2.2

—

Any operation in hilmo

5.13

3.01

2.7

1.3

—

Primary biliary cholangitis (PBC)

4.32

3.00

1.0

1.9

—

Short stature, not elsewhere classified

4.20

2.90

1.0

1.3

—

Otitis externa

314

1.63

2.80

1.2

1.6

—

207.60

iu/ml

—

Persons encountering health services in other circumstances

557

1.46

2.76

1.5

1.8

—

314.91

—

Schizophrenia or delusion

471

1.49

2.63

1.3

1.7

—

135.11

iu/ml

—

Schizophrenia, schizotypal and delusional disorders

472

1.49

2.61

1.3

1.7

—

135.11

iu/ml

—

Unspecified fall

105

749

1.38

2.59

1.3

1.7

—

128.92

iu/ml

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

7.25

2.56

1.0

2.6

—

Lung transplant status

7.25

2.56

1.6

2.6

—

Lung transplantation

7.25

2.56

1.6

2.6

—

Blindness, monocular

7.22

2.55

1.6

2.7

—

Failed attempted abortion

7.20

2.55

1.0

2.9

—

iu/ml

—

Internal derangement of knee

406

1.51

2.53

1.5

2.0

—

70.11

iu/ml

—

Unspecified mental disorder

600

1.42

2.51

1.3

1.8

—

136.91

iu/ml

—

Other symptoms and signs involving cognitive functions and awareness

575

1.40

2.50

1.6

—

79.71

iu/ml

—

Pulmonary heart disease, diseases of pulmonary circulation

396

1.52

2.49

1.2

1.7

—

176.33

iu/ml

—

Recurrent or chronic depression

419

1.42

2.47

1.5

1.8

—

260.18

iu/ml

—

Assault by sharp object

3.84

2.47

1.5

1.8

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

454

1.48

2.46

1.3

1.6

—

161.43

—

Acute tubulo-interstitial nephritis

113

709

1.35

2.40

1.7

1.6

—

193.17

iu/ml

—

Aspergillosis

6.33

2.38

1.2

1.1

—

Aspergillosis, including avohilmo

6.32

2.38

1.2

1.1

—

Alcohol induced polyneuropathy

6.31

2.38

1.2

1.4

—

Pulmonary embolism

363

1.52

2.30

1.2

1.7

—

176.33

iu/ml

—

Pulmonary heart disease

364

1.51

2.28

1.2

1.7

—

176.33

iu/ml

—

Selective serotonin reuptake inhibitors

193

800

1.25

2.27

1.6

1.7

—

201.94

iu/ml

—

Fall on same level involving ice and snow

115

871

1.32

2.22

1.5

1.7

—

146.65

—

Adrenocortical insufficiency

3.12

2.22

1.1

1.8

—

Exophthalmic conditions

5.61

2.22

1.2

2.6

—

Other and unspecified aplastic anaemias

5.60

2.22

5.0

1.2

—

Diseases of external ear

490

1.43

2.21

1.2

1.6

—

159.86

iu/ml

—

DVT of lower extremities and pulmonary embolism

525

1.40

2.12

1.2

1.7

—

182.25

iu/ml

—

Kela-code for severe mental illness

537

1.40

2.10

1.3

1.7

—

136.91

iu/ml

—

Stomatitis and related lesions

275

1.57

2.10

1.7

1.6

—

213.60

iu/ml

—

Spondylosis

101

590

1.34

2.09

1.6

—

47143091.71

iu/ml

—

Primary adrenocortical insufficiency

5.04

2.07

1.0

2.2

—

Other viral diseases, not elsewhere classified, including avohilmo

387

1.47

2.06

1.1

1.9

—

136.91

—

Other specified and unspecified disorders of eyelid

4.03

2.04

1.0

2.0

—

Low back pain

150

801

1.26

2.02

1.7

1.6

—

25384864.31

iu/ml

—

Complications predominantly related to the puerperium

326

0.52

2.00

1.6

1.8

—

367.14

—

Assault by other specified means

4.59

1.94

2.2

2.1

—

Speech and linguistic disorders, excluding more controls

1.94

1.92

1.1

1.8

—

213.40

iu/ml

—

Intestinal stricture

396

1.44

1.91

1.5

—

195.80

—

1.96

1.89

2.0

—

268.20

iu/ml

—

Traumatic subarachnoid haemorrhage

2.87

1.86

1.1

1.9

—

Ectropion of eyelid

2.87

1.86

1.1

1.8

—

Insulin, fast-acting (human)

197

0.46

1.83

1.8

—

207.60

—

Candidiasis, including avohilmo

409

1.42

1.81

1.7

1.8

—

173.63

iu/ml

—

Intracranial trauma

117

616

1.28

1.81

1.5

1.8

—

166.09

iu/ml

—

Erosion of teeth , including avohilmo

402

1.42

1.79

1.3

1.8

—

149.20

—

Medicines for HER+ breast cancer

432

0.62

1.78

1.8

1.6

—

273.14

—

Injuries to the hip and thigh

604

1.32

1.78

1.6

—

157.78

iu/ml

—

Assault by blunt object

3.36

1.75

1.3

1.7

—

Residual foreign body in soft tissue

2.23

1.74

1.1

1.6

—

Fitting and adjustment of other devices

394

0.63

1.72

1.8

1.6

—

195.50

iu/ml

—

Lifestyle-related condition

3.88

1.72

1.0

2.5

—

Personal history of risk-factors, not elsewhere classified

3.87

1.72

1.0

2.4

—

Venous thromboembolism

679

1.31

1.71

1.4

1.7

—

164.56

iu/ml

—

Panic disorder

194

1.60

1.71

1.8

1.6

—

170.86

iu/ml

—

Nerve, nerve root and plexus disorders

203

1018

1.20

1.67

1.8

1.7

55000180.17

202.08

iu/ml

—

Herpesviral [herpes simplex] infections, including avohilmo

342

1.43

1.65

1.5

1.7

—

195.57

iu/ml

—

Nonorganic sleeping disorders, excluding more controls

277

1.48

1.63

2.0

1.8

—

149.10

iu/ml

—

Other factor of the environment

3.60

1.62

1.0

2.4

—

Infections specific to the perinatal period

3.60

1.62

4.0

1.9

—

Femoral hernia, unilateral

3.01

1.58

1.7

1.6

—

Inguinal hernia, unilateral

3.01

1.58

1.7

—

Inguinal of femoral hernia, unilateral

3.01

1.58

1.7

1.6

—

Benign neoplasm: Colon

690

1.28

1.53

2.0

1.6

—

198.43

iu/ml

—

L02BG Aromatase inhibitors

365

0.62

1.49

2.0

1.7

—

237.00

—

Type 1 diabetes, strict definition

125

0.40

1.49

1.2

2.0

—

216.80

—

Pediculosis, acariasis and other infestations, including avohilmo

243

1.48

1.46

1.2

1.6

—

213.60

—

Benign neoplasm of colon, rectum, anus and anal canal

112

761

1.24

1.45

1.9

1.6

—

36666822.44

iu/ml

—

Loose body in joint

3.14

1.44

1.0

1.7

—

Type 1 diabetes, strict (exclude DM2)

151

0.46

1.43

1.1

1.9

—

183.17

—

Haemorrhagic and haematological disorders of fetus and newborn

2.62

1.36

1.5

1.2

—

Fracture at wrist and hand level

536

1.30

1.35

1.3

1.7

—

131.50

—

Type of accident

417

1.34

1.4

1.6

—

161.43

—

KRA_PSY_EATING, excluding more controls

1.78

1.33

1.1

1.9

—

225.67

—

Fracture of shoulder and upper arm

513

1.31

1.32

1.8

1.7

—

154.90

iu/ml

—

Type 1 diabetes, definitions combined

150

0.46

1.30

1.1

1.9

—

183.17

—

Mycoses

394

1.35

1.30

1.4

1.6

—

207.60

iu/ml

—

Other and unspecified tonsillitis

449

1.30

1.29

1.7

1.9

—

223.83

—

Subjective visual disturbances

344

1.37

1.27

1.4

1.5

—

205.40

iu/ml

—

Other disorders of adrenal gland

2.05

1.27

1.1

2.0

—

Polyarthrosis

138

1.57

1.25

1.0

2.0

—

Ischaemic Stroke, excluding all haemorrhages

584

0.77

1.25

1.2

1.7

—

197.00

iu/ml

—

Speech and linguistic disorders

110

1.66

1.24

1.1

1.8

—

213.40

iu/ml

—

Diffuse brain injury

2.23

1.24

2.1

1.9

—

Behavioural syndromes associated with physiological disturbances and physical factors

180

1041

1.17

1.24

1.8

1.7

146.20

202.73

iu/ml

—

Accidental poisoning by and exposure to alcohol

2.64

1.21

1.0

2.0

—

Excessive earwax

896

0.80

1.21

1.3

1.6

—

25384774.08

iu/ml

—

Non-selective monoamine reuptake inhibitors

466

1.30

1.21

1.4

1.7

—

218.13

iu/ml

—

Other predominantly sexually transmitted diseases, not elsewhere classified

221

1.45

1.20

1.4

1.9

—

200.86

iu/ml

—

Sleep disorders (combined)

212

959

1.15

1.19

1.7

108.43

23571643.79

iu/ml

—

Anisometropia and aniseikonia

2.11

1.18

1.4

1.7

—

Osteoporosis

281

1.37

1.17

1.8

—

267.00

iu/ml

—

Other articular cartilage disorders

2.51

1.15

1.2

2.0

—

Paralytic ileus and intestinal obstruction

335

1.34

1.12

1.5

1.6

—

209.00

—

Fall on and from stairs and steps

353

1.33

1.11

1.2

1.5

—

207.60

—

Small fibre neuropathy

2.19

1.08

1.9

1.7

—

iu/ml

—

Symptoms and signs involving emotional state

2.13

1.05

1.6

2.0

—

Iridocyclitis

305

1.35

1.04

1.6

—

207.60

—

Leiomyoma of uterus

437

1.22

1.04

2.1

1.6

214.60

240.20

iu/ml

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

571

1.24

1.03

1.6

1.7

—

137.45

iu/ml

—

Other sexually transmitted chlamydial diseases, including avohilmo

138

1.52

1.02

2.2

1.7

—

184.50

—

Other diseases of upper respiratory tract

205

937

1.14

1.01

1.7

99.20

244.38

iu/ml

—

Disorders of orbit

1.88

1.00

1.1

1.4

—

Gestational [pregnancy-induced] hypertension

309

0.68

1.00

1.6

1.8

—

382.50

—

Superficial injury of lower leg

369

1.30

0.99

1.6

1.7

—

138.00

—

Toxic effect of alcohol

2.18

0.98

1.4

1.9

—

Hyperaldosteronism

0.00

0.97

0.0

1.8

—

Schizophrenia

232

1.38

0.97

1.3

1.8

—

161.43

—

Vertical strabismus

1.90

0.94

1.0

1.7

—

Other noninfective gastroenteritis and colitis

321

1.31

0.92

1.1

1.6

—

183.17

iu/ml

—

Migraine with aura

350

0.71

0.91

1.3

1.8

—

328.88

iu/ml

—

Concussion

610

1.19

0.91

1.8

—

166.09

iu/ml

—

Nonorganic sleeping disorders

313

1.31

0.91

2.0

1.7

—

183.17

iu/ml

—

Injuries to the thorax

681

1.20

0.89

1.5

1.6

—

143.75

iu/ml

—

Cystitis

145

748

1.15

0.89

1.7

1.6

—

251.69

iu/ml

—

Cervical disc disorders

484

1.24

0.87

1.9

1.6

—

273.67

—

Other congenital malformations of circulatory system

2.01

0.87

1.2

1.7

—

D07AA Corticosteroids, weak (group I)

203

1.38

0.86

1.6

—

213.60

—

Injuries to the neck

334

1.29

0.85

2.3

1.8

—

138.00

iu/ml

—

Scabies, including avohilmo

204

1.37

0.84

1.1

1.5

—

213.60

—

Acute and subacute iridocyclitis

256

1.33

0.84

1.8

1.6

—

207.60

—

Hyperkinetic disorders, excluding more controls

143

1.44

0.84

1.3

2.1

—

162.22

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

513

0.79

0.83

1.6

1.7

—

291.92

—

Sleep disorders

168

1023

1.13

0.82

1.8

1.7

146.20

202.73

iu/ml

—

Nonsuppurative otitis media

292

1.28

0.80

1.3

1.7

—

238.30

iu/ml

—

Periodontal disease, other/unspecified

0.00

0.79

0.0

1.8

—

Disturbances of skin sensation

383

1.25

0.79

1.4

1.9

—

175.00

—

Systemic connective tissue disorders

455

1.23

0.79

1.2

1.7

—

203.86

iu/ml

—

Intracranial injury

104

834

1.16

0.78

1.7

—

136.79

iu/ml

—

Acute nasopharyngitis (common cold)

173

0.63

0.77

1.1

2.1

—

178.17

—

Congenital malformations of great arteries

0.00

0.77

0.0

1.7

—

Obesity due to excess calories

704

1.18

0.76

1.5

1.7

—

220.25

iu/ml

—

Atopic dermatitis, strict definition with reimbursement

413

1.23

0.76

1.7

—

312.38

—

Pyogenic arthritis

1.70

0.75

1.3

2.4

—

iu/ml

—

Focal brain injury

1.64

0.75

1.7

1.8

—

Short Achilles tendon (acquired)

2.09

0.74

1.0

1.4

—

Other spirochaetal diseases

491

0.79

0.72

1.1

1.6

—

173.63

—

1.99

0.72

1.0

1.2

—

Spirochaetal infections, other/unspecified, including avohilmo

489

0.80

0.70

1.1

1.6

—

173.63

—

Other facial nerve disorders

1.93

0.70

1.2

1.6

—

Other spirochaetal diseases, including avohilmo

500

0.80

0.70

1.1

1.6

—

173.63

—

Osteoporosis with pathological fracture (FG)

1.71

0.70

1.0

2.4

—

iu/ml

—

Respiratory and cardiovascular disorders specific to the perinatal period

1.87

0.68

2.6

1.7

—

Muscle strain

1.85

0.68

1.4

1.5

—

Lyme disease, including avohilmo

485

0.80

0.67

1.1

1.6

—

173.63

—

Lyme disease

485

0.80

0.67

1.1

1.6

—

173.63

—

Polyarthritis, unspecified

1.79

0.66

1.4

3.2

—

Retinal detachments and breaks

475

1.20

0.66

1.4

1.6

—

206.43

—

Phobic anxiety disorders

179

1.34

0.65

1.1

1.6

—

183.00

—

Urinary track infection

402

1.16

0.65

2.1

1.5

—

302.56

iu/ml

—

Polycystic ovarian syndrome, broad definition

128

0.62

0.63

2.9

1.9

—

268.20

—

Spontaneous abortion

396

0.83

0.62

1.8

1.6

—

321.63

iu/ml

—

Contact with sharp object, undetermined intent

1.67

0.61

2.0

1.9

—

Infective bursitis

1.67

0.61

1.0

1.4

—

Venous complications and haemorrhoids in pregnancy

0.00

0.60

0.0

1.8

—

Bursitis of shoulder

0.00

0.60

0.0

1.5

—

Malignant neoplasm of breast, including Hilmo

320

0.82

0.58

1.5

1.4

—

302.40

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

320

0.82

0.58

1.5

1.4

—

302.40

—

Fracture of lower leg, including ankle

821

1.14

0.58

1.4

1.7

—

141.94

iu/ml

—

Sixth [abducent] nerve palsy

1.72

0.57

1.3

1.7

—

Acute and transient psychotic disorders

149

1.34

0.57

1.5

1.7

—

213.60

iu/ml

—

Migraine with aura and triptan purchases

219

0.73

0.57

1.3

2.0

—

220.80

—

Pedal cyclist injured in transport accident

319

1.22

0.56

1.5

1.6

—

183.17

—

Malignant neoplasm of breast

320

0.83

0.55

1.5

1.4

—

302.40

—

Malignant neoplasm of breast, HER2-negative

320

0.83

0.55

1.5

1.4

—

302.40

—

Anterior Iridocyclitis

275

1.24

0.55

1.8

1.7

—

207.60

—

Endometriosis of pelvic peritoneum

197

0.74

0.54

2.4

1.8

—

246.00

—

Insomnia

161

1020

1.10

0.53

1.8

1.7

146.20

202.73

iu/ml

—

Other specified/unspecified soft tissue disorders

1.54

0.53

1.0

1.6

—

Infectious mononucleosis, including avohilmo

108

1.39

0.53

1.1

1.9

—

213.60

—

Infectious mononucleosis

108

1.39

0.53

1.1

1.9

—

213.60

—

Nonsuppurative otitis media, including avohilmo

421

1.17

0.53

1.3

1.8

—

225.42

iu/ml

—

Other diseases of lip and oral mucosa

620

1.15

0.51

1.3

1.7

—

164.92

iu/ml

—

Disorders of synovium and tendon

669

1.13

0.50

2.0

1.7

47142994.00

71.11

iu/ml

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

470

1.14

0.49

1.4

1.7

—

306.64

iu/ml

—

Pregnancy hypertension

462

0.85

0.47

1.4

1.8

—

306.64

—

Non-allergic asthma (mode)

216

1.24

0.46

1.5

1.7

—

207.40

—

Synovial cyst of popliteal space [Baker]

0.62

0.45

1.0

1.8

—

Tonsillectomy and adenotomy

101

632

1.11

0.45

1.3

1.9

—

218.33

iu/ml

—

Adverse effects, not elsewhere classified

265

0.79

0.45

2.0

1.7

—

215.80

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

219

1.23

0.45

1.4

1.8

—

268.20

—

Non-allergic asthma (mode), excluding more controls

217

1.23

0.44

1.5

1.8

—

217.83

—

Other disorders of eyelid

548

1.14

0.44

1.1

1.5

—

93.80

—

Disorders of vitreous body and globe

684

1.12

0.43

2.0

1.6

—

197.10

iu/ml

—

Lateral epicondylitis

163

0.74

0.43

1.1

1.8

—

Female infertility, associated with anovulation

0.64

0.42

3.5

1.7

—

456.00

—

Impotence

1.43

0.41

1.1

1.5

—

Other disorders originating in the perinatal period

0.00

0.41

0.0

2.0

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

0.00

0.41

0.0

2.1

—

Other and unspecified injuries of abdomen, lower back and pelvis

0.00

0.41

0.0

1.9

—

Other specified and unspecified strabismus

0.00

0.41

0.0

2.2

—

Anomalies of dental arch relationship, including avohilmo

256

0.81

0.41

1.4

1.7

—

213.60

—

Polyp of the female genital tract

241

0.85

0.41

1.7

—

246.00

iu/ml

—

Basal cell carcinoma, including Hilmo

408

1.13

0.40

1.8

1.4

—

197.80

iu/ml

—

Third [oculomotor] nerve palsy

0.00

0.40

0.0

2.0

—

Plantar fascial fibromatosis

114

1.32

0.40

3.3

1.8

—

Trigeminal neuralgia

1.33

0.40

1.0

2.1

—

Conotruncal defects

0.00

0.40

0.0

1.9

—

Deviated nasal septum

502

1.13

0.39

2.1

1.8

—

184.67

—

Viral warts, including avohilmo

325

1.17

0.39

1.2

1.6

—

183.17

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

581

1.12

0.38

1.5

1.7

—

231.71

—

Childhood allergy (age < 16)

169

1.22

0.38

1.4

1.6

—

41.40

—

Superficial injury of wrist and hand

307

1.17

0.38

1.2

1.8

—

151.38

—

Hyperprolactinaemia

1.35

0.37

4.0

1.9

—

Pilonidal cyst

116

1.29

0.37

1.3

1.9

—

216.80

—

Superficial injury of head

336

1.16

0.36

2.3

1.6

—

207.60

iu/ml

—

Medical treatment for female infertility

223

1.20

0.36

1.6

1.8

—

382.50

iu/ml

—

Other diseases of gallbladder

1.43

0.35

1.5

—

Fracture of rib(s), sternum and thoracic spine

413

1.14

0.35

1.5

1.6

—

207.60

—

Other systemic involvement of connective tissue

338

1.15

0.35

1.2

1.6

—

205.40

iu/ml

—

Endometriosis of ovary

209

0.81

0.34

3.7

1.8

—

246.00

—

Childhood asthma (age<16), excluding more controls

134

1.22

0.34

1.4

1.9

—

322.43

—

Urolithiasis

443

1.13

0.33

2.3

1.6

—

207.60

iu/ml

—

Presence of other functional implants

564

1.09

0.33

1.6

—

207.57

iu/ml

—

Other functional intestinal disorders

611

1.10

0.32

1.4

1.6

—

177.36

—

Disorders of psychological development

161

1.21

0.31

1.1

1.7

—

213.40

iu/ml

—

Open wound of lower leg

193

1.19

0.30

1.4

1.8

—

213.60

—

Actinic keratosis

406

1.12

0.30

1.8

1.6

—

267.00

iu/ml

—

Childhood asthma (age<16)

136

1.21

0.30

1.4

1.9

—

322.43

—

Suppurative and unspecified otitis media

512

0.90

0.29

1.3

1.8

—

198.93

iu/ml

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

441

0.88

0.29

1.6

1.7

—

162.33

—

Lesion of lateral popliteal nerve

1.25

0.29

3.1

1.5

—

Calculus of kidney and ureter

401

1.12

0.29

2.4

1.6

—

207.60

—

Atopic dermatitis, strict definition

421

1.11

0.28

1.7

—

136.91

—

Dysplasia of cervi uteri

235

0.87

0.28

1.6

1.7

—

456.00

iu/ml

—

Car occupant injured in other and unspecified transport accidents

261

1.15

0.27

2.6

1.8

—

183.17

iu/ml

—

Degeneration of macula and posterior pole

465

1.09

0.27

2.2

1.6

—

227.67

iu/ml

—

Other and unspecified effects of external causes

403

1.12

0.27

1.8

1.7

—

136.91

—

Endometriosis

280

0.89

0.27

2.5

1.7

—

401.67

iu/ml

—

Angina pectoris

528

1.08

0.26

1.4

1.7

—

55000225.17

iu/ml

—

Lesion of plantar nerve

1.19

0.26

1.0

1.9

—

Disorders of vitreous body

677

1.08

0.26

2.1

1.6

—

197.10

iu/ml

—

Obesity related asthma

508

0.91

0.25

1.5

1.6

—

254.67

iu/ml

—

Other fall from one level to another

329

0.88

0.24

1.3

1.7

—

161.43

iu/ml

—

Other and unspecified disorders of vitreous body

579

1.08

0.22

1.8

1.6

—

198.43

iu/ml

—

SLE (Finngen)

1.22

0.22

1.0

2.2

—

Congenital malformations of pulmonary and tricuspid valves

0.00

0.21

0.0

2.6

—

Other mosquito-borne viral fevers, including avohilmo

0.00

0.21

0.0

2.7

—

Seminoma of testis

0.00

0.21

0.0

1.6

—

Xanthelasma of eyelid

0.00

0.21

0.0

2.5

—

Other congenital malformations, not elsewhere classified

0.00

0.21

0.0

2.5

—

Symptoms and signs involving appearance and behaviour

0.00

0.21

0.0

2.5

—

Congenital malformations of eyelid, lacrimal apparatus and orbit

0.00

0.21

0.0

2.4

—

Acute mastoiditis

0.00

0.21

0.0

1.5

—

Seminoma of testis, including Hilmo

0.00

0.21

0.0

2.0

—

Burns classified according to extent of body surface involved

0.00

0.21

0.0

2.5

—

Unspecified threat to breathing

0.00

0.21

0.0

2.5

—

Synovial hypertrophy, not elsewhere classified

0.00

0.21

0.0

1.3

—

Other bursitis, not elsewhere classified

0.00

0.21

0.0

1.2

—

Migraine with aura, drug-induced

0.00

0.21

0.0

2.2

—

Caries in Clefts patients

0.00

0.21

0.0

2.3

—

Other bursal cyst

0.00

0.21

0.0

1.2

—

COPD

505

1.08

0.21

1.2

1.7

—

269.20

iu/ml

—

Injury of muscle and tendon at wrist and hand level

182

1.15

0.21

2.8

1.7

—

213.60

—

Atypical virus infections of central nervous system

0.00

0.21

0.0

2.4

—

Atypical virus infections of central nervous system, including avohilmo

0.00

0.21

0.0

2.4

—

Prominent ears

0.00

0.21

0.0

2.3

—

Phakomatoses, not elsewhere classified

0.00

0.21

0.0

2.2

—

Unspecified maternal hypertension

0.00

0.21

0.0

3.0

—

Other chondrocalcinosis

0.00

0.21

0.0

1.2

—

Other and unspecified trigeminal disorders

0.00

0.21

0.0

2.4

—

Hyperlipidaemia, other/unspecified

464

1.08

0.21

1.9

1.6

—

270.20

iu/ml

—

Palmar fascial fibromatosis [Dupuytren]

154

1.17

0.21

1.7

1.6

—

Cleft palate

0.00

0.21

0.0

2.0

—

Diseases caused by chlamydiae, including avohilmo

0.00

0.21

0.0

2.3

—

Isolated patent ductus arteriosus

0.00

0.20

0.0

2.1

—

Triptan medication for migraine, min. 3 purchases

645

0.94

0.20

1.2

1.7

—

216.93

iu/ml

—

Coarctation of the aorta

0.00

0.20

0.0

2.1

—

Other congenital malformations of ear

0.00

0.20

0.0

2.1

—

Superficial injury of ankle and foot

164

1.16

0.20

3.7

1.6

—

213.60

—

Stroke, excluding SAH

607

0.94

0.20

1.2

1.7

—

41250172.38

iu/ml

—

Extrapyramidal and movement disorders

509

0.92

0.19

1.4

1.7

—

182.25

iu/ml

—

All dysplastic lesions of the cervix uteri, vagina or vulva

330

1.09

0.17

1.5

1.7

—

382.50

iu/ml

—

Seronegative rheumatoid arthritis

1.21

0.17

1.9

2.2

—

All dysplastic lesions of the cervix uteri

286

1.10

0.17

1.5

1.8

—

382.50

iu/ml

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

455

0.92

0.17

1.5

1.6

—

300.80

—

Glucagon-like peptide-1 (GLP-1) analogues

455

0.92

0.17

1.5

1.6

—

300.80

—

Other chronic obstructive pulmonary disease

483

1.07

0.17

1.2

1.7

—

269.20

iu/ml

—

444

1.07

0.17

1.8

1.6

—

267.00

iu/ml

—

Ovarian cyst

283

1.07

0.15

1.1

1.7

—

401.67

iu/ml

—

Special screening examination for neoplasms

0.75

0.15

1.0

1.4

—

Hypothyroidism, other/unspecified

142

898

1.04

0.15

1.6

79.50

269.25

iu/ml

—

Fracture of forearm

771

1.05

0.15

1.3

1.7

—

139.94

—

Skin changes due to chronic exposure to nonionizing radiation

424

1.07

0.14

1.8

1.7

—

267.00

iu/ml

—

Irritable bowel syndrome

391

1.07

0.14

1.4

1.7

—

163.11

—

Inflammatory diseases of female pelvic organs

574

1.05

0.14

1.3

1.7

—

291.92

iu/ml

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

290

1.08

0.14

1.2

1.8

—

264.00

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

314

1.08

0.14

1.9

1.6

—

256.80

—

Other/unspecified seropositive rheumatoid arthritis

314

1.08

0.14

1.9

1.6

—

256.80

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

460

1.07

0.14

1.3

1.6

—

185.83

iu/ml

—

Injuries to the elbow and forearm

119

986

1.03

0.11

1.4

1.7

—

203.83

—

Asthma, including avohilmo

197

1112

0.97

0.11

1.5

1.7

66000036.00

224.50

iu/ml

—

Seropositive rheumatoid arthritis, wide

318

1.07

0.11

1.9

1.6

—

256.80

—

Stroke, including SAH

648

0.96

0.11

1.2

1.7

—

41250172.38

iu/ml

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

145

923

1.03

0.10

1.6

79.50

269.25

iu/ml

—

Basal cell carcinoma

397

1.05

0.10

1.9

1.4

—

197.80

iu/ml

—

Pre-eclampsia

239

0.92

0.10

1.2

1.8

—

268.20

—

Preterm labour and delivery

300

0.93

0.10

1.3

1.7

—

336.60

iu/ml

—

All influenza (not pneumonia)

193

1.09

0.09

1.0

1.8

—

207.60

—

Superficial injury of abdomen, lower back and pelvis

207

0.92

0.09

1.7

—

213.60

iu/ml

—

Uterine polyps

234

0.95

0.08

1.3

1.7

—

246.00

iu/ml

—

Diseases of tongue

0.79

0.08

1.0

1.5

—

Excessive, frequent and irregular menstruation

292

1.04

0.08

1.9

1.7

—

401.67

iu/ml

—

Olecranon bursitis

1.09

0.08

2.9

1.6

—

Carcinoma in situ of cervix uteri

112

0.89

0.07

1.3

1.8

—

268.20

iu/ml

—

Other/unspecified enthesopathies, not elsewhere classified

0.83

0.07

1.9

1.8

—

iu/ml

—

Endometriosis ASRM stages 3,4

255

0.94

0.07

3.0

1.6

—

264.20

—

Hyperkinetic disorders

201

1.07

0.06

1.3

1.8

—

162.57

—

Spontaneous rupture of synovium and tendon

0.85

0.06

2.6

1.8

—

iu/ml

—

Haemorrhage in early pregnancy

326

0.95

0.06

1.5

1.7

—

481.50

iu/ml

—

In situ neoplasms

512

1.04

0.06

2.0

1.7

—

197.33

iu/ml

—

Acute suppurative otitis media

377

1.04

0.05

1.3

1.8

—

138.64

iu/ml

—

Pre-eclampsia or eclampsia

263

0.95

0.05

1.2

1.8

—

268.20

—

Abrasion of teeth

514

1.03

0.05

1.6

1.7

—

197.10

—

Disturbance of activity and attention

194

1.06

0.04

1.3

1.8

—

162.57

—

Foreign body on external eye

221

0.95

0.04

2.0

1.8

—

178.17

—

Conduction disorders

295

1.03

0.03

1.1

1.7

—

208.60

—

HSIL lesion of the cervix uteri, vagina or vulva

230

0.96

0.03

1.6

1.9

—

231.67

iu/ml

—

Acute laryngitis and tracheitis

168

1.05

0.03

1.5

1.8

—

159.00

—

Other arrhythmias

713

1.02

0.03

1.5

1.8

—

156.71

iu/ml

—

Contraceptive management

448

0.98

0.02

1.1

1.8

—

200.00

—

HSIL lesion of the cervix uteri

207

0.97

0.01

1.7

1.9

—

268.20

iu/ml

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

638

1.01

0.01

1.6

—

282.33

iu/ml

—

Generalized anxiety disorder

216

0.97

0.01

1.1

1.7

—

202.14

—

Diseases of middle ear and mastoid

748

0.99

0.00

1.5

1.8

—

205.94

iu/ml

—

Diseases of salivary glands

456

0.99

0.00

1.5

1.6

—

160.11

iu/ml

—

Diseases of the ear and mastoid process

197

988

1.00

0.00

1.8

1.7

79.00

20625211.06

iu/ml

—

Conjunctivitis (acute, non atopic)

411

0.99

0.00

1.8

1.7

—

145.38

—

Procreative management

453

1.00

0.00

1.4

1.8

—

139.38

iu/ml

—

Viral and other specified intestinal infections

288

0.98

0.00

1.4

1.8

—

162.57

iu/ml

—

Effects of foreign body entering through natural orifice

366

1.01

0.00

1.8

1.7

—

161.43

—

Ectopic pregnancy

186

1.02

0.00

1.1

1.8

—

224.00

—

Pre-eclampsia or poor fetal growth

359

1.00

0.00

1.2

1.8

—

382.50

—

Noninflammatory disorders of female genital tract

294

0.99

0.00

2.4

1.7

—

401.67

iu/ml

—

Otitis media, unspecified

137

1.01

0.00

1.5

1.7

—

180.33

—

Maternal care for other conditions predominantly related to pregnancy

234

1.00

0.00

1.6

1.7

—

573.80

iu/ml

—

Poor fetal growth

137

1.02

0.00

1.3

1.9

—

268.20

—

Rheumatoid arthritis, including avohilmo

514

0.99

0.00

1.6

1.7

—

182.25

—

Lesion of femoral nerve

0.00

0.0

3.2

—

Abnormal pulmonary venous return

0.00

0.0

1.0

—

Atrioventricular septal defect

0.00

0.0

1.3

—

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

0.00

0.0

3.0

—

Burns and corrosions of multiple body regions

0.00

0.0

1.6

—

Acute myringitis

0.00

0.0

2.8

—

Mandibular hypoplasia

0.00

0.0

3.2

—

Congenital aortic valve stenosis

0.00

0.0

3.2

—

Ectopic testis

0.00

0.0

1.0

—

Acquired keratosis [keratoderma] palmaris et plantaris

0.00

0.0

3.2

—

Congenital ichthyosis

0.00

0.0

3.2

—

Tetraplegia

0.00

0.0

2.8

—

Thyrotropin deficiency

0.00

0.0

2.9

—

Carcinoma in situ of cervix uteri, exocervix

0.00

0.0

3.4

—

Birth asphyxia

0.00

0.0

2.9

—

Congenital malformations of posterior segment of eye

0.00

0.0

1.0

—

Other congenital malformations of heart

0.00

0.0

1.1

—

Other and unspecified heterotropia

0.00

-0.00

0.0

1.4

—

Congenital lens malformations

0.00

-0.00

0.0

3.6

—

Other and unspecified disorders of pigmentation

0.00

-0.00

0.0

2.9

—

Other congenital malformations of female genitalia

0.00

-0.00

0.0

3.0

—

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

0.00

-0.00

0.0

3.2

—

Rifle, shotgun and larger firearm discharge

0.00

-0.00

0.0

1.6

—

Hypospadias

0.00

-0.00

0.0

1.0

—

Other osteochondrodysplasias

0.00

-0.00

0.0

2.7

—

Other and unspecified papulosquamous disorders

0.00

-0.00

0.0

2.8

—

Neurofibromatosis, type 1

0.00

-0.00

0.0

3.6

—

Impaction of intestines

0.00

-0.00

0.0

3.0

—

Benign neoplasm: Retina

0.00

-0.00

0.0

2.6

—

Benign neoplasm: Testis

0.00

-0.00

0.0

1.5

—

Unattended death

0.00

-0.00

0.0

1.4

—

Carcinoma in situ of oral cavity, oesophagus and stomach

0.00

-0.00

0.0

3.3

—

Carcinoma in situ of prostate

0.00

-0.00

0.0

1.6

—

Palatinal maxillary canine

0.00

-0.00

0.0

1.4

—

Palatinal maxillary operation

0.00

-0.00

0.0

1.4

—

Toxic effect of corrosive substances

0.00

-0.00

0.0

3.6

—

Injury of nerves at ankle and foot level

0.00

-0.00

0.0

2.6

—

Effects of heat and light

0.00

-0.00

0.0

3.2

—

Toxic effect of other gases, fumes and vapours

0.00

-0.00

0.0

3.4

—

Accessory breast

0.00

-0.00

0.0

3.2

—

Fall involving playground equipment

0.00

-0.00

0.0

1.1

—

Contact with other specified venomous animals

0.00

-0.00

0.0

3.0

—

Congenital ptosis, including avohilmo

0.00

-0.00

0.0

3.2

—

Spermatocele

0.90

-0.00

1.9

1.5

—

iu/ml

—

Congenital malformations of anterior segment of eye

0.00

-0.00

0.0

2.6

—

Chorioretinal scars

0.00

-0.00

0.0

3.2

—

Contact with other and unspecified heat and hot substances

0.00

-0.00

0.0

3.3

—

Occupant of pick-up truck or van injured in other and unspecified transport accidents

0.00

-0.00

0.0

1.4

—

Other specified and unspecified disorders of iris and ciliary body

0.00

-0.00

0.0

3.6

—

Left side

0.00

-0.00

0.0

3.2

—

Vascular dementia (multiple infarctions)

0.00

-0.00

0.0

1.0

—

Other disorders affecting eyelid function

0.00

-0.00

0.0

2.9

—

Need for immunization against single bacterial diseases

0.00

-0.00

0.0

3.2

—

Liveborn infants according to place of birth

0.00

-0.00

0.0

1.5

—

Injury of cranial nerves

0.00

-0.00

0.0

3.4

—

Generalized pustular psoriasis

0.00

-0.00

0.0

3.6

—

Disorders of adrenal gland, other and/or unspecified

0.00

-0.00

0.0

3.2

—

Disorders of aromatic amino-acid metabolism

0.00

-0.00

0.0

3.2

—

Syndrome of inappropriate secretion of antidiuretic hormone

0.00

-0.00

0.0

3.2

—

Other congenital malformations of kidney

0.00

-0.00

0.0

3.2

—

Other and unspecified disorders of binocular movement

0.00

-0.00

0.0

3.2

—

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

0.00

-0.00

0.0

1.3

—

Disorders of purine and pyrimidine metabolism

0.00

-0.00

0.0

2.6

—

Acromegaly and pituitary gigantism

0.00

-0.00

0.0

3.3

—

Cervical root disorders

0.00

-0.00

0.0

2.8

—

Occupant of special vehicle mainly used on industrial premises injured in transport accident

0.00

-0.00

0.0

1.4

—

Malignant neoplasm of lip, including Hilmo

0.00

-0.00

0.0

1.0

—

Intercostal neuropathy

0.00

-0.00

0.0

2.6

—

Infarction of spleen

0.00

-0.00

0.0

2.8

—

Implicit parasitic Sepsis, including avohilmo

0.00

-0.00

0.0

1.2

—

Tarsal tunnel syndrome

0.00

-0.00

0.0

2.6

—

Benign neoplasm: Orbit, unspecified

0.00

-0.00

0.0

2.7

—

Corneal pigmentations and deposits

0.00

-0.00

0.0

3.8

—

Complex cardiac defects

0.00

-0.00

0.0

1.6

—

Non-seminoma of testis, including Hilmo

0.00

-0.00

0.0

1.3

—

ILD medications: pirfenidone

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Scrotum

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of other and unspecified parts of mouth, including Hilmo

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of gallbladder, including Hilmo

0.00

-0.00

0.0

1.0

—

Other specified/unspecified nutritional deficiencies

0.00

-0.00

0.0

1.4

—

Deaf mutism, not elsewhere classified

0.00

-0.00

0.0

1.8

—

Malignant neoplasm of base of tongue, including Hilmo

0.00

-0.00

0.0

3.4

—

Hereditary deficiency of other clotting factors

0.00

-0.00

0.0

3.1

—

Gangrene, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Toxoplasmosis, including avohilmo

0.00

-0.00

0.0

2.9

—

Malignant neoplasm of other and unspecified parts of mouth

0.00

-0.00

0.0

1.0

—

Toxoplasmosis

0.00

-0.00

0.0

2.9

—

Cholinergic urticaria

0.00

-0.00

0.0

1.4

—

Shigellosis, including avohilmo

0.00

-0.00

0.0

4.0

—

Malignant neoplasm of base of tongue

0.00

-0.00

0.0

2.3

—

Meningococcal infection, including avohilmo

0.00

-0.00

0.0

3.0

—

Diseases caused by chlamydiae

0.00

-0.00

0.0

2.9

—

Feeding problems of newborn

0.00

-0.00

0.0

1.6

—

Congenital malformations of ear causing impairment of hearing

0.00

-0.00

0.0

3.6

—

Congenital stenosis of pulmonary valve

0.00

-0.00

0.0

2.6

—

Meningococcal infection

0.00

-0.00

0.0

3.0

—

Congenital malformations of great veins

0.00

-0.00

0.0

1.0

—

Congenital malformations of cardiac chambers and connections

0.00

-0.00

0.0

1.0

—

Marfan's syndrome

0.00

-0.00

0.0

3.3

—

Use of riluzole

0.00

-0.00

0.0

1.0

—

Congenital cataract

0.00

-0.00

0.0

3.6

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS